Peapack Gladstone Financial Corp / EW
Peapack Gladstone Financial Corp’s Edwards Lifesciences Corp Position
Does Peapack Gladstone Financial Corp own Edwards Lifesciences Corp (EW)? Yes — 225.2K shares worth $18M (+0.23% of its 13F portfolio) as of Q1 2026, down from 261.4K shares the prior filed quarter.
Position Value
$18M
Q1 2026
Shares
225.2K
% of Portfolio
+0.23%
Quarters Held
29
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 225.2K | $18M | +0.23% |
| Q4 2025 | 261.4K | $22M | +0.28% |
| Q3 2025 | 269.7K | $21M | +0.27% |
| Q2 2025 | 265.4K | $21M | +0.29% |
| Q1 2025 | 270.1K | $20M | +0.29% |
| Q4 2024 | 288.4K | $21M | +0.31% |
| Q3 2024 | 293.8K | $19M | +0.28% |
| Q2 2024 | 141.2K | $13M | +0.20% |
| Q1 2024 | 134.2K | $13M | +0.20% |
| Q4 2023 | 100.4K | $8M | +0.13% |
| Q3 2023 | 90.2K | $6M | +0.12% |
| Q2 2023 | 97.7K | $9M | +0.16% |
| Q1 2023 | 84.2K | $7M | +0.13% |
| Q4 2022 | 105.2K | $8M | +0.15% |
| Q3 2022 | 67.0K | $6M | +0.11% |
| Q2 2022 | 56.5K | $5M | +0.12% |
| Q1 2022 | 25.3K | $3M | +0.06% |
| Q4 2021 | 21.0K | $3M | +0.05% |
| Q3 2021 | 18.7K | $2M | +0.04% |
| Q2 2021 | 15.8K | $2M | +0.04% |
| Q1 2021 | 10.7K | $893,000 | +0.02% |
| Q4 2020 | 28.0K | $3M | +0.08% |
| Q3 2020 | 28.6K | $2M | +0.08% |
| Q2 2020 | 6.6K | $456,000 | +0.02% |
| Q1 2020 | 2.2K | $420,000 | +0.02% |
| Q4 2019 | 2.1K | $484,000 | +0.02% |
| Q3 2019 | 2.1K | $468,000 | +0.02% |
| Q2 2019 | 2.3K | $421,000 | +0.02% |
| Q1 2019 | 1.1K | $214,000 | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peapack Gladstone Financial Corp’s full portfolio or all institutional holders of EW.